Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 4/10

vs
industry
vs
history
Cash-to-Debt 0.05
AMS's Cash-to-Debt is ranked lower than
71% of the 267 Companies
in the Global Medical Care industry.

( Industry Median: 0.37 vs. AMS: 0.05 )
Ranked among companies with meaningful Cash-to-Debt only.
AMS' s Cash-to-Debt Range Over the Past 10 Years
Min: 0  Med: 0.21 Max: 1.04
Current: 0.05
0
1.04
Equity-to-Asset 0.37
AMS's Equity-to-Asset is ranked lower than
69% of the 261 Companies
in the Global Medical Care industry.

( Industry Median: 0.50 vs. AMS: 0.37 )
Ranked among companies with meaningful Equity-to-Asset only.
AMS' s Equity-to-Asset Range Over the Past 10 Years
Min: -0.58  Med: 0.31 Max: 0.43
Current: 0.37
-0.58
0.43
Debt-to-Equity 1.11
AMS's Debt-to-Equity is ranked lower than
73% of the 193 Companies
in the Global Medical Care industry.

( Industry Median: 0.63 vs. AMS: 1.11 )
Ranked among companies with meaningful Debt-to-Equity only.
AMS' s Debt-to-Equity Range Over the Past 10 Years
Min: -24.5  Med: 1.63 Max: 31.39
Current: 1.11
-24.5
31.39
Debt-to-EBITDA 2.14
AMS's Debt-to-EBITDA is ranked higher than
63% of the 197 Companies
in the Global Medical Care industry.

( Industry Median: 2.82 vs. AMS: 2.14 )
Ranked among companies with meaningful Debt-to-EBITDA only.
AMS' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 2.14  Med: 3.91 Max: 5.05
Current: 2.14
2.14
5.05
Interest Coverage 1.84
AMS's Interest Coverage is ranked lower than
83% of the 224 Companies
in the Global Medical Care industry.

( Industry Median: 7.55 vs. AMS: 1.84 )
Ranked among companies with meaningful Interest Coverage only.
AMS' s Interest Coverage Range Over the Past 10 Years
Min: 0.32  Med: 0.62 Max: 1.93
Current: 1.84
0.32
1.93
Piotroski F-Score: 8
Altman Z-Score: 0.99
Beneish M-Score: -2.89
WACC vs ROIC
13.56%
4.29%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 6/10

vs
industry
vs
history
Operating Margin % 16.95
AMS's Operating Margin % is ranked higher than
87% of the 267 Companies
in the Global Medical Care industry.

( Industry Median: 7.34 vs. AMS: 16.95 )
Ranked among companies with meaningful Operating Margin % only.
AMS' s Operating Margin % Range Over the Past 10 Years
Min: -0.32  Med: 6.76 Max: 17.57
Current: 16.95
-0.32
17.57
Net Margin % 4.90
AMS's Net Margin % is ranked higher than
61% of the 267 Companies
in the Global Medical Care industry.

( Industry Median: 4.16 vs. AMS: 4.90 )
Ranked among companies with meaningful Net Margin % only.
AMS' s Net Margin % Range Over the Past 10 Years
Min: -9.2  Med: 0.28 Max: 4.97
Current: 4.9
-9.2
4.97
ROE % 4.41
AMS's ROE % is ranked lower than
64% of the 250 Companies
in the Global Medical Care industry.

( Industry Median: 9.23 vs. AMS: 4.41 )
Ranked among companies with meaningful ROE % only.
AMS' s ROE % Range Over the Past 10 Years
Min: -7.33  Med: 0.24 Max: 4.93
Current: 4.41
-7.33
4.93
ROA % 1.60
AMS's ROA % is ranked lower than
61% of the 269 Companies
in the Global Medical Care industry.

( Industry Median: 3.45 vs. AMS: 1.60 )
Ranked among companies with meaningful ROA % only.
AMS' s ROA % Range Over the Past 10 Years
Min: -2.5  Med: 0.07 Max: 1.67
Current: 1.6
-2.5
1.67
ROC (Joel Greenblatt) % 9.28
AMS's ROC (Joel Greenblatt) % is ranked lower than
59% of the 269 Companies
in the Global Medical Care industry.

( Industry Median: 14.51 vs. AMS: 9.28 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
AMS' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 1.97  Med: 5.59 Max: 9.38
Current: 9.28
1.97
9.38
3-Year Revenue Growth Rate -4.30
AMS's 3-Year Revenue Growth Rate is ranked lower than
83% of the 209 Companies
in the Global Medical Care industry.

( Industry Median: 7.70 vs. AMS: -4.30 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
AMS' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -37.4  Med: -3.1 Max: 44.2
Current: -4.3
-37.4
44.2
3-Year EBITDA Growth Rate 4.20
AMS's 3-Year EBITDA Growth Rate is ranked lower than
59% of the 186 Companies
in the Global Medical Care industry.

( Industry Median: 7.10 vs. AMS: 4.20 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
AMS' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -46.4  Med: -0.3 Max: 147.4
Current: 4.2
-46.4
147.4
» AMS's 30-Y Financials

Financials (Next Earnings Date: 2018-03-23)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

AMS Guru Trades in

Q1 2017

AMS Guru Trades in Q1 2017

David Swensen 59,211 sh (New)
Jim Simons 31,200 sh (New)
» More
Q2 2017

AMS Guru Trades in Q2 2017

Jim Simons 72,000 sh (+130.77%)
David Swensen Sold Out
» More
Q3 2017

AMS Guru Trades in Q3 2017

Jim Simons 67,790 sh (-5.85%)
» More
» Details

Insider Trades

Latest Guru Trades with AMS

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
David Swensen 2017-06-30 Sold Out 0.05%$3.8 - $4.75 $ 2.65-37%0
David Swensen 2017-03-31 New Buy0.05%$3.35 - $4.53 $ 2.65-35%59,211
Premium More recent guru trades are included for Premium Members only!!
Premium More recent guru trades are included for USA Subscribe Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Health Care Providers » Medical Care    NAICS: 621999    SIC: 8071
Compare:BOM:523696, TSXV:CXV, FRA:EIF, HKSE:08161, BOM:530163, WAR:POM, HKSE:00648, SGX:505, ASX:TFG, BKK:NEW, OTCPK:MIHI, JSE:AVL, TSXV:CMM, AMEX:SSY, OTCPK:PFHO, BOM:539428, LSE:WDC, TSE:6063, OTCPK:HPHW, LSE:VENN » details
Traded in other countries:AZS.Germany,
Headquarter Location:USA
American Shared Hospital Services provides technology solutions for advanced radiosurgical and radiation therapy services. The company also provides Gamma Knife radiosurgery equipment, and offers IGRT and IMRT systems, as well as proton therapy equipment.

American Shared Hospital Services provides technology solutions for advanced radiosurgical and radiation therapy services. The company also provides Gamma Knife radiosurgery equipment, and offers IGRT and IMRT systems, as well as proton therapy equipment.

Top Ranked Articles about American Shared Hospital Services

David Swensen Sells 5 Holdings, Buys 2 Others An overview of the guru's 1st-quarter trades
David Swensen (Trades, Portfolio) is responsible for managing Yale University's endowment assets and investment funds. He manages a portfolio of six stocks worth $495 million. During the first quarter, the guru traded shares in the following stocks: Read more...

Ratios

vs
industry
vs
history
PE Ratio 15.59
AMS's PE Ratio is ranked higher than
85% of the 200 Companies
in the Global Medical Care industry.

( Industry Median: 26.57 vs. AMS: 15.59 )
Ranked among companies with meaningful PE Ratio only.
AMS' s PE Ratio Range Over the Past 10 Years
Min: 9.11  Med: 23.92 Max: 406.25
Current: 15.59
9.11
406.25
PE Ratio without NRI 15.59
AMS's PE Ratio without NRI is ranked higher than
87% of the 196 Companies
in the Global Medical Care industry.

( Industry Median: 26.50 vs. AMS: 15.59 )
Ranked among companies with meaningful PE Ratio without NRI only.
AMS' s PE Ratio without NRI Range Over the Past 10 Years
Min: 9.11  Med: 23.92 Max: 400
Current: 15.59
9.11
400
Price-to-Owner-Earnings 4.66
AMS's Price-to-Owner-Earnings is ranked higher than
95% of the 106 Companies
in the Global Medical Care industry.

( Industry Median: 26.22 vs. AMS: 4.66 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
AMS' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 2.09  Med: 6.58 Max: 114.58
Current: 4.66
2.09
114.58
PB Ratio 0.69
AMS's PB Ratio is ranked higher than
96% of the 251 Companies
in the Global Medical Care industry.

( Industry Median: 2.62 vs. AMS: 0.69 )
Ranked among companies with meaningful PB Ratio only.
AMS' s PB Ratio Range Over the Past 10 Years
Min: 0.26  Med: 0.66 Max: 1.77
Current: 0.69
0.26
1.77
PS Ratio 0.81
AMS's PS Ratio is ranked higher than
73% of the 259 Companies
in the Global Medical Care industry.

( Industry Median: 1.70 vs. AMS: 0.81 )
Ranked among companies with meaningful PS Ratio only.
AMS' s PS Ratio Range Over the Past 10 Years
Min: 0.24  Med: 0.76 Max: 1.64
Current: 0.81
0.24
1.64
Price-to-Free-Cash-Flow 2.48
AMS's Price-to-Free-Cash-Flow is ranked higher than
97% of the 124 Companies
in the Global Medical Care industry.

( Industry Median: 22.48 vs. AMS: 2.48 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
AMS' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 0.87  Med: 2.37 Max: 56
Current: 2.48
0.87
56
Price-to-Operating-Cash-Flow 2.05
AMS's Price-to-Operating-Cash-Flow is ranked higher than
97% of the 179 Companies
in the Global Medical Care industry.

( Industry Median: 14.62 vs. AMS: 2.05 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
AMS' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 0.59  Med: 1.77 Max: 3.66
Current: 2.05
0.59
3.66
EV-to-EBIT 8.70
AMS's EV-to-EBIT is ranked higher than
95% of the 209 Companies
in the Global Medical Care industry.

( Industry Median: 20.85 vs. AMS: 8.70 )
Ranked among companies with meaningful EV-to-EBIT only.
AMS' s EV-to-EBIT Range Over the Past 10 Years
Min: 6.9  Med: 13.6 Max: 75.6
Current: 8.7
6.9
75.6
EV-to-EBITDA 3.85
AMS's EV-to-EBITDA is ranked higher than
97% of the 227 Companies
in the Global Medical Care industry.

( Industry Median: 15.17 vs. AMS: 3.85 )
Ranked among companies with meaningful EV-to-EBITDA only.
AMS' s EV-to-EBITDA Range Over the Past 10 Years
Min: 2.9  Med: 5 Max: 7.2
Current: 3.85
2.9
7.2
EV-to-Revenue 2.29
AMS's EV-to-Revenue is ranked lower than
51% of the 265 Companies
in the Global Medical Care industry.

( Industry Median: 2.18 vs. AMS: 2.29 )
Ranked among companies with meaningful EV-to-Revenue only.
AMS' s EV-to-Revenue Range Over the Past 10 Years
Min: 1.5  Med: 2.6 Max: 3.6
Current: 2.29
1.5
3.6
Current Ratio 1.03
AMS's Current Ratio is ranked lower than
64% of the 253 Companies
in the Global Medical Care industry.

( Industry Median: 1.41 vs. AMS: 1.03 )
Ranked among companies with meaningful Current Ratio only.
AMS' s Current Ratio Range Over the Past 10 Years
Min: 0.12  Med: 1.05 Max: 4.13
Current: 1.03
0.12
4.13
Quick Ratio 1.03
AMS's Quick Ratio is ranked lower than
60% of the 253 Companies
in the Global Medical Care industry.

( Industry Median: 1.31 vs. AMS: 1.03 )
Ranked among companies with meaningful Quick Ratio only.
AMS' s Quick Ratio Range Over the Past 10 Years
Min: 0.12  Med: 1.04 Max: 4.13
Current: 1.03
0.12
4.13
Days Sales Outstanding 99.88
AMS's Days Sales Outstanding is ranked lower than
88% of the 220 Companies
in the Global Medical Care industry.

( Industry Median: 41.26 vs. AMS: 99.88 )
Ranked among companies with meaningful Days Sales Outstanding only.
AMS' s Days Sales Outstanding Range Over the Past 10 Years
Min: 67.01  Med: 79.54 Max: 99.88
Current: 99.88
67.01
99.88
Days Payable 9.32
AMS's Days Payable is ranked lower than
94% of the 159 Companies
in the Global Medical Care industry.

( Industry Median: 51.14 vs. AMS: 9.32 )
Ranked among companies with meaningful Days Payable only.
AMS' s Days Payable Range Over the Past 10 Years
Min: 7.13  Med: 12.43 Max: 21.73
Current: 9.32
7.13
21.73

Buy Back

vs
industry
vs
history
3-Year Average Share Buyback Ratio -5.90
AMS's 3-Year Average Share Buyback Ratio is ranked lower than
61% of the 159 Companies
in the Global Medical Care industry.

( Industry Median: -2.50 vs. AMS: -5.90 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
AMS' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -18.5  Med: -1.4 Max: 8
Current: -5.9
-18.5
8

Valuation & Return

vs
industry
vs
history
Price-to-Tangible-Book 0.68
AMS's Price-to-Tangible-Book is ranked higher than
96% of the 193 Companies
in the Global Medical Care industry.

( Industry Median: 3.46 vs. AMS: 0.68 )
Ranked among companies with meaningful Price-to-Tangible-Book only.
AMS' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 0.27  Med: 0.77 Max: 5.96
Current: 0.68
0.27
5.96
Price-to-Intrinsic-Value-Projected-FCF 0.29
AMS's Price-to-Intrinsic-Value-Projected-FCF is ranked higher than
98% of the 103 Companies
in the Global Medical Care industry.

( Industry Median: 1.98 vs. AMS: 0.29 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
AMS' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 0.04  Med: 0.26 Max: 0.54
Current: 0.29
0.04
0.54
Price-to-Median-PS-Value 1.06
AMS's Price-to-Median-PS-Value is ranked lower than
56% of the 232 Companies
in the Global Medical Care industry.

( Industry Median: 1.03 vs. AMS: 1.06 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
AMS' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.04  Med: 0.9 Max: 3.06
Current: 1.06
0.04
3.06
Price-to-Graham-Number 0.69
AMS's Price-to-Graham-Number is ranked higher than
92% of the 124 Companies
in the Global Medical Care industry.

( Industry Median: 2.26 vs. AMS: 0.69 )
Ranked among companies with meaningful Price-to-Graham-Number only.
AMS' s Price-to-Graham-Number Range Over the Past 10 Years
Min: 0.09  Med: 0.95 Max: 3.29
Current: 0.69
0.09
3.29
Earnings Yield (Greenblatt) % 11.49
AMS's Earnings Yield (Greenblatt) % is ranked higher than
96% of the 269 Companies
in the Global Medical Care industry.

( Industry Median: 3.79 vs. AMS: 11.49 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
AMS' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: 1.3  Med: 7.3 Max: 14.4
Current: 11.49
1.3
14.4
Forward Rate of Return (Yacktman) % 35.21
AMS's Forward Rate of Return (Yacktman) % is ranked higher than
90% of the 128 Companies
in the Global Medical Care industry.

( Industry Median: 8.93 vs. AMS: 35.21 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
AMS' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: 8.5  Med: 23.4 Max: 57
Current: 35.21
8.5
57

More Statistics

Revenue (TTM) (Mil) $19.53
EPS (TTM) $ 0.17
Beta1.15
Short Percentage of Float0.12%
52-Week Range $2.55 - 5.00
Shares Outstanding (Mil)5.71

Piotroski F-Score Details

Piotroski F-Score: 88
Positive ROAY
Positive CFROAY
Higher ROA yoyY
CFROA > ROAY
Lower Leverage yoyY
Higher Current Ratio yoyY
Less Shares Outstanding yoyN
Higher Gross Margin yoyY
Higher Asset Turnover yoyY

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}